Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 329

Similar articles for PubMed (Select 10716993)

1.

Activin receptor-like kinase 1 modulates transforming growth factor-beta 1 signaling in the regulation of angiogenesis.

Oh SP, Seki T, Goss KA, Imamura T, Yi Y, Donahoe PK, Li L, Miyazono K, ten Dijke P, Kim S, Li E.

Proc Natl Acad Sci U S A. 2000 Mar 14;97(6):2626-31.

2.

Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.

Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P.

EMBO J. 2002 Apr 2;21(7):1743-53.

3.

Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.

Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.

J Biol Chem. 1997 Aug 22;272(34):21187-94.

4.

Endoglin null endothelial cells proliferate faster and are more responsive to transforming growth factor beta1 with higher affinity receptors and an activated Alk1 pathway.

Pece-Barbara N, Vera S, Kathirkamathamby K, Liebner S, Di Guglielmo GM, Dejana E, Wrana JL, Letarte M.

J Biol Chem. 2005 Jul 29;280(30):27800-8. Epub 2005 May 27.

5.

Activin receptor-like kinase (ALK)1 is an antagonistic mediator of lateral TGFbeta/ALK5 signaling.

Goumans MJ, Valdimarsdottir G, Itoh S, Lebrin F, Larsson J, Mummery C, Karlsson S, ten Dijke P.

Mol Cell. 2003 Oct;12(4):817-28.

PMID:
14580334
6.

Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Lebrin F, Goumans MJ, Jonker L, Carvalho RL, Valdimarsdottir G, Thorikay M, Mummery C, Arthur HM, ten Dijke P.

EMBO J. 2004 Oct 13;23(20):4018-28. Epub 2004 Sep 23.

7.

Poor vessel formation in embryos from knock-in mice expressing ALK5 with L45 loop mutation defective in Smad activation.

Itoh F, Itoh S, Carvalho RL, Adachi T, Ema M, Goumans MJ, Larsson J, Karlsson S, Takahashi S, Mummery CL, Dijke PT, Kato M.

Lab Invest. 2009 Jul;89(7):800-10. doi: 10.1038/labinvest.2009.37. Epub 2009 Apr 27.

8.

Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.

Wu X, Ma J, Han JD, Wang N, Chen YG.

Microvasc Res. 2006 Jan;71(1):12-9. Epub 2006 Jan 5.

PMID:
16405919
9.

ALK5 phosphorylation of the endoglin cytoplasmic domain regulates Smad1/5/8 signaling and endothelial cell migration.

Ray BN, Lee NY, How T, Blobe GC.

Carcinogenesis. 2010 Mar;31(3):435-41. doi: 10.1093/carcin/bgp327. Epub 2009 Dec 30.

10.

TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.

König HG, Kögel D, Rami A, Prehn JH.

J Cell Biol. 2005 Mar 28;168(7):1077-86. Epub 2005 Mar 21.

11.

Hereditary hemorrhagic telangiectasia, a vascular dysplasia affecting the TGF-beta signaling pathway.

Fernández-L A, Sanz-Rodriguez F, Blanco FJ, Bernabéu C, Botella LM.

Clin Med Res. 2006 Mar;4(1):66-78. Review.

12.

Transforming growth factor-beta- and Activin-Smad signaling pathways are activated at distinct maturation stages of the thymopoeisis.

Rosendahl A, Speletas M, Leandersson K, Ivars F, Sideras P.

Int Immunol. 2003 Dec;15(12):1401-14.

13.

Increase in ALK1/ALK5 ratio as a cause for elevated MMP-13 expression in osteoarthritis in humans and mice.

Blaney Davidson EN, Remst DF, Vitters EL, van Beuningen HM, Blom AB, Goumans MJ, van den Berg WB, van der Kraan PM.

J Immunol. 2009 Jun 15;182(12):7937-45. doi: 10.4049/jimmunol.0803991. Erratum in: J Immunol. 2010 Aug 15;185(4):2629.

14.

ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.

Finnson KW, Parker WL, ten Dijke P, Thorikay M, Philip A.

J Bone Miner Res. 2008 Jun;23(6):896-906. doi: 10.1359/jbmr.080209.

PMID:
18333754
15.

Mechanisms of TGF-β-induced differentiation in human vascular smooth muscle cells.

Tang Y, Yang X, Friesel RE, Vary CP, Liaw L.

J Vasc Res. 2011;48(6):485-94. doi: 10.1159/000327776. Epub 2011 Aug 11.

16.

Ionizing radiation shifts the PAI-1/ID-1 balance and activates notch signaling in endothelial cells.

Scharpfenecker M, Kruse JJ, Sprong D, Russell NS, Ten Dijke P, Stewart FA.

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):506-13. doi: 10.1016/j.ijrobp.2008.09.052.

PMID:
19147015
17.

Defective paracrine signalling by TGFbeta in yolk sac vasculature of endoglin mutant mice: a paradigm for hereditary haemorrhagic telangiectasia.

Carvalho RL, Jonker L, Goumans MJ, Larsson J, Bouwman P, Karlsson S, Dijke PT, Arthur HM, Mummery CL.

Development. 2004 Dec;131(24):6237-47. Epub 2004 Nov 17.

18.

Controlling the angiogenic switch: a balance between two distinct TGF-b receptor signaling pathways.

Goumans MJ, Lebrin F, Valdimarsdottir G.

Trends Cardiovasc Med. 2003 Oct;13(7):301-7. Review.

PMID:
14522471
19.

Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.

Larsson J, Goumans MJ, Sjöstrand LJ, van Rooijen MA, Ward D, Levéen P, Xu X, ten Dijke P, Mummery CL, Karlsson S.

EMBO J. 2001 Apr 2;20(7):1663-73.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk